📰 3 sources covering this story

HSE approves reimbursement of Skyclarys for Friedreich’s ataxia patients

First covered 3 hrs ago · latest take 1 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

HSE approves reimbursement of Skyclarys for Friedreich’s ataxia patients
HSE approves reimbursement of Skyclarys for Friedreich’s ataxia patients
Decision reverses recommendation made by HSE Drugs Group two weeks ago
Irish Times
Irish Times🏁 first to report3 hrs ago
Decision due on HSE funding for treatment for rare genetic disorder
The drug omaveloxolone, branded as Skyclarys, was approved in the US for the treatment of the disease, followed by Europe
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →